Here’s an interesting take on the potential for mega discipline against scores of players arising out of Biogenesis.
Richard McLaren is an attorney who has presided as an arbitrator over multiple arbitration cases exactly like the one which may involve Alex Rodriguez, Ryan Braun and others in the event they get disciplined: appeals of non-analytical cases. Meaning drug suspensions based on testimony or other evidence as opposed to a positive drug test.
He appeared on on the MLB Network Radio channel on SiriusXM with Mike Ferrin and Jim Duquette today, and talked a lot about the potential Biogenesis appeals and how difficult they may be for Major League Baseball given that their star witness is Anthony Bosch. The key takeaway: “Credibility is everything. If he turns out to not be a credible witness, there’s not much of a case.”
Not that it’d be impossible. McLaren notes what anyone who has dealt with criminal doings or drug-related unseemliness knows: there are a lot of scumbags hanging around. And he talks about ways Major League Baseball can deal with his prima facie credibility problems. But it’s impossible to deny that if Major League Baseball does proceed with Bosch out front of its case against the players, making any discipline stick is going to be a pretty risky proposition.
Blue Jays right-hander Marcus Stroman might be headed to the disabled list soon, manager John Gibbons told reporters following Friday’s rain-shortened loss to the Yankees. The righty lasted just four innings on the mound before calling it a night, and gave up five runs, six hits and two walks in a performance that Gibbons claimed was at least partially affected by recurring blister issues on his right middle finger. Now, it looks like he might be removed from the rotation for some much-needed rest and rehabilitation; if so, it’ll be his second such stint this year.
Stroman, 27, has struggled to return the kind of winning record and sub-4.00 ERA that characterized his previous seasons with the club, mostly due to the combined seven weeks he missed with blisters on his throwing hand and chronic fatigue in his right shoulder. In a recent start against the Rays, things got even more gruesome when his blister appeared to start bleeding in the middle of his outing and MLB.com’s Gregor Chisholm notes that the wound has constantly interfered with the right-hander’s pitch selection and delivery. When healthy, Stroman has managed a 4-8 record through 18 starts in 2018 with a career-worst 5.27 ERA, 3.2 BB/9 and 6.8 SO/9 in 100 2/3 innings. This will be the first year since 2015 in which he has not logged at least 200 innings in a single season.
While Stroman may not need an extended stay on the DL before he returns to the mound, it’s not clear what kind of timetable the Blue Jays expect for his recovery. He’s been the second-most valuable starter (behind the now-traded J.A. Happ) in a rotation that currently ranks 17th in the majors with a combined 4.90 ERA and 6.8 fWAR.